20 research outputs found

    Autoconocimiento, monitorización y complicaciones de la diabetes en la jornada No más ciegos por diabetes en Antioquia, 2005 Self-knowledge, control and complications of diabetes at no more blind by diabetes session in Antioquia, 2005

    No full text
    INTRODUCCIÓN: una sólida educación a los pacientes en temas relacionados con la diabetes y la monitorización de la glucosa, se han asociado con mejor control metabólico, mayor entendimiento de la enfermedad, auto confianza y mejor cuidado clínico. MATERIALES Y MÉTODOS: estudio de corte transversal, en la jornada No más ciegos por diabetes en Antioquia 2005. Se diligenció un cuestionario indagando acerca de la monitorización, tipo de diabetes, tratamiento y complicaciones; se midieron la glucometría, el peso, la talla y el perímetro abdominal. RESULTADOS: se incluyeron 210 pacientes, de los cuales 36,6% no saben que tipo de diabetes tienen, 59,7% no saben que es la hemoglobina glicosilada y 25,8% saben que este examen debe realizarse cada 3 a 4 meses, sin embargo, solo se le había realizado a siete pacientes (3,3%) con la frecuencia ideal. El 36,4% tienen glucómetro y 60,6% de los pacientes saben que se deben realizarse una evaluación oftalmológica anual. En los pacientes con Diabetes Mellitus tipo 2 el 26,2% tuvo glucometrías postprandial menores de 140 mg/dl. Las complicaciones informadas con mayor frecuencia fueron el compromiso renal y descompensación aguda en los Diabéticos tipo 1, la dislipidemia y la neuropatía periférica en los diabéticos tipo 2. INTRODUCTION: A better knowledge about diabetes by patients has been associated with better understanding of the disease, self esteem and improved clinical care and metabolic control. MATERIAL AND METHODS: It is a cohort study, made during the “No more blind by Diabetes” session, 2005. The study population fills out the form with questions about the blood glucose control, type of diabetes and treatment. Also a measure of blood glucose, height, weight, and abdominal circumference was made. RESULTS: 210 patients were included, 36.6% did not know which type of diabetes they have, 59.7% did not know what glycosylated hemoglobin is, 25.8% know that the frequency to evaluated this test is about 3 o 4 months, but only 3.3% had the recommended frequency. The 36.4% has glucose monitors and 60.6% know that the frequency of eye examination should be annual. In type 2 diabetic patients, only 26.2% had glucose test in the ideal range for postprandial glucose (less than 140 mg/dl). Kidney disease and acute hyperglycemic crises with impaired mental status were the most frequently complications reported by patients with type 1 diabetes, meanwhile neuropathy and lipid problems were the most frequently complications reported by patients with type 2 diabetes

    Type A aortic dissection secondary to a left common carotid artery dissection

    No full text
    Common carotid artery dissection is an unusual clinical event that most commonly occurs secondary to type A aortic dissection. We present a rare case of spontaneous common carotid artery dissection temporally preceding aortic dissection. Our case highlights the careful attention that cases of common carotid dissection should be given; our knowledge base regarding their natural history and evidence-based management is distinctly lacking compared to dissection of other cervical vessels. It also demonstrates the importance of imaging the entire aorta at the time of, a seemingly isolated, common carotid dissection to exclude other potential synchronous dissections. Keywords: Aortic dissection, Common carotid artery dissectio

    Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

    No full text

    Alirocumab and cardiovascular outcomes after acute coronary syndrome

    No full text
    BACKGROUN

    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

    No full text

    Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

    No full text
    BACKGROUN

    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

    No full text

    Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial

    No full text

    Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

    No full text
    corecore